Millennium Management
NVCT icon

Millennium Management’s Nuvectis Pharma NVCT Stock Holding History

Millennium Management’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31,167
Closed -$233K – 6323
2025
Q2 		$233K Sell
31,167
-89,934
-74% -$816K ﹤0.01% 5298
2025
Q1 		$1.18M Buy
121,101
+91,403
+308% +$658K ﹤0.01% 4232
2024
Q4 		$161K Sell
29,698
-38,801
-57% -$243K ﹤0.01% 5375
2024
Q3 		$431K Sell
68,499
-50,960
-43% -$335K ﹤0.01% 4942
2024
Q2 		$756K Buy
119,459
+79,958
+202% +$543K ﹤0.01% 4315
2024
Q1 		$324K Buy
39,501
+5,490
+16% +$46.7K ﹤0.01% 5093
2023
Q4 		$284K Buy
+34,011
New +$303K ﹤0.01% 4987
2023
Q2 		– Sell
-24,667
Closed -$323K – 6514
2023
Q1 		$323K Buy
+24,667
New +$250K ﹤0.01% 4862
2022
Q2 		– Sell
-42,160
Closed -$312K – 7333
2022
Q1 		$312K Buy
+42,160
New +$293K ﹤0.01% 5501

Other funds holding NVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Millennium Management's NVCT Position: Q3 2025 in Review

Millennium Management sold out of Nuvectis Pharma (NVCT) in Q3 2025, closing a stake of 31,167 shares — an estimated $233K sold.

Millennium Management first reported a position in NVCT in Q1 2022 and held it in 9 quarters. The position peaked at $1.18M in Q1 2025. 53 funds tracked by Wall St. Rank hold NVCT as of Q3 2025.

  • Millennium Management reported no remaining Nuvectis Pharma position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 31,167 Nuvectis Pharma shares in Q3 2025, an estimated $233K.
  • Millennium Management first reported a position in Nuvectis Pharma in Q1 2022 and held it in 9 quarters.
  • Millennium Management's Nuvectis Pharma position peaked at $1.18M in Q1 2025.
  • 53 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.